The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Pfizer
Stock and Other Ownership Interests - Audentes Therapeutics; Clovis Oncology; Pfizer
Travel, Accommodations, Expenses - Pfizer
Talapro-2: A 2-part, placebo-controlled phase 3 study of talazoparib (TALA) with background enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage repair deficiencies.
 
Neeraj Agarwal
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Cerulean Pharma; Clovis Oncology; Eisai; EMD Serono; Exelixis; Genentech/Roche; Medivation/Astellas; Merck; Nektar; Novartis; Pfizer
Research Funding - Amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Arun Azad
Honoraria - Amgen; Astellas Pharma; Janssen; Novartis; Pfizer; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Janssen
Research Funding - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma; Sanofi
 
Andre Fay
No Relationships to Disclose
 
Joan Carles
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Johnson & Johnson; Pfizer; Sanofi
Speakers' Bureau - Bayer; Johnson & Johnson
 
Neal D. Shore
Leadership - Large Urology Group Practice Association
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Dendreon; Ferring; Genentech/Roche; Janssen Scientific Affairs; Medivation/Astellas; Myovant Sciences; Pfizer; Sanofi; Tolmar
 
Luke T. Nordquist
No Relationships to Disclose
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation/Astellas
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation/Astellas
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Medivation
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen (Inst); Medivation/Astellas (Inst); Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; dendreon; Janssen; Medivation/Astellas; Spectrum Pharmaceuticals
 
Curtis Dunshee
Research Funding - Astellas Medivation (Inst); BHR Pharma (Inst); Churchill Pharmaceuticals (Inst); Dendreon (Inst); Eleven Biotherapeutics (Inst); Ferring (Inst); Janssen Oncology (Inst); Myovant Sciences (Inst); pfizer (Inst); Siemens (Inst)
 
Srinand Ponnathapura Nandakumar
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Beth Sullivan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Akos Czibere
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Fong Wang
No Relationships to Disclose
 
Karim Fizazi
Honoraria - Astellas Pharma
Consulting or Advisory Role - Astellas Pharma